These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9924299

  • 21. Effect of lodoxamide on tear leukotriene levels in giant papillary conjunctivitis associated with ocular prosthesis.
    Akman A, Irkeç M, Orhan M, Erdener U.
    Ocul Immunol Inflamm; 1998 Sep; 6(3):179-84. PubMed ID: 9785608
    [Abstract] [Full Text] [Related]

  • 22. Lodoxamide for vernal keratoconjunctivitis.
    Med Lett Drugs Ther; 1994 Mar 18; 36(918):26. PubMed ID: 8121328
    [No Abstract] [Full Text] [Related]

  • 23. Antiallergic activity of topical lodoxamide on in vivo and in vitro models.
    Ciprandi G, Buscaglia S, Catrullo A, Paolieri F, Riccio AM, Fiorino N, Canonica GW.
    Allergy; 1996 Dec 18; 51(12):946-51. PubMed ID: 9020426
    [Abstract] [Full Text] [Related]

  • 24. [In vitro effects of antiallergic eyedrops on complement activation induced by particulate matter].
    Blondin C, Cholley B, Haeffner-Cavaillon N, Goldschmidt P.
    J Fr Ophtalmol; 2003 Apr 18; 26(4):328-36. PubMed ID: 12843888
    [Abstract] [Full Text] [Related]

  • 25. [Alomide, a preventive immunopharmaceutical agent, in the treatment of ocular atopy].
    Krásný J.
    Cesk Slov Oftalmol; 1998 Jan 18; 54(1):41-5. PubMed ID: 9501643
    [Abstract] [Full Text] [Related]

  • 26. A critical look at ocular allergy drugs.
    Joseph Titi M.
    Am Fam Physician; 1996 Jun 18; 53(8):2637-42, 2645-6. PubMed ID: 8644576
    [Abstract] [Full Text] [Related]

  • 27. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.
    Leonardi A, Borghesan F, Avarello A, Plebani M, Secchi AG.
    Br J Ophthalmol; 1997 Jan 18; 81(1):23-6. PubMed ID: 9135403
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of N-acetyl aspartyl glutamic acid versus fluorometholone for treating allergic conjunctivitis in an environmental exposure chamber.
    de Blay F, Gherasim A, Domis N, Choual I, Bourcier T.
    Clin Exp Allergy; 2022 Sep 18; 52(9):1091-1100. PubMed ID: 35302688
    [Abstract] [Full Text] [Related]

  • 29. [N-acetyl-aspartylglutamic acid eye drops in allergic-type conjuctivitis. Double-blind comparative clinical study].
    Bonnet M, Ducournau D, Lumbroso P, Serpin G.
    J Fr Ophtalmol; 1985 Sep 18; 8(8-9):573-8. PubMed ID: 3936869
    [Abstract] [Full Text] [Related]

  • 30. Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients.
    Leonardi A, Bremond-Gignac D, Bortolotti M, Violato D, Pouliquen P, Delval L, Grouin JM, Fregona IA.
    Br J Ophthalmol; 2007 Dec 18; 91(12):1662-6. PubMed ID: 17585003
    [Abstract] [Full Text] [Related]

  • 31. Tear histamine and histaminase during the early (EPR) and late (LPR) phases of the allergic reaction and the effects of lodoxamide.
    Leonardi AA, Smith LM, Fregona IA, Salmaso M, Secchi AG.
    Eur J Ophthalmol; 1996 Dec 18; 6(2):106-12. PubMed ID: 8823580
    [Abstract] [Full Text] [Related]

  • 32. [An efficacy study of lodoxamide treatment in allergic eye lesions].
    Giuri S, Munteanu GH.
    Oftalmologia; 2000 Dec 18; 50(1):68-76. PubMed ID: 11021110
    [Abstract] [Full Text] [Related]

  • 33. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: a double-blind placebo-controlled study.
    Mann JS, Clement P, Sheridan AQ, Soryal I, Fairfax AJ, Holgate ST.
    J Allergy Clin Immunol; 1985 Jul 18; 76(1):83-90. PubMed ID: 4008815
    [Abstract] [Full Text] [Related]

  • 34. Effects of ketotifen 0.025% and lodoxamide 0.1% on eosinophil infiltration into the guinea pig conjunctiva in a model of allergic conjunctivitis.
    Schoch C.
    J Ocul Pharmacol Ther; 2003 Apr 18; 19(2):153-9. PubMed ID: 12804060
    [Abstract] [Full Text] [Related]

  • 35. N-acetyl-aspartyl glutamic acid (NAAGA) topical eyedrops in the treatment of giant papillary conjunctivitis (GPC).
    Meijer F, Pogany K, Kok JH, Kijlstra A.
    Doc Ophthalmol; 1993 Apr 18; 85(1):5-11. PubMed ID: 7910133
    [Abstract] [Full Text] [Related]

  • 36. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB, Torkildsen GL, Williams JI, Gow JA, Gomes PJ, McNamara TR, Bepotastine Besilate Ophthalmic Solutions Clinical Study Group.
    Clin Ther; 2009 Sep 18; 31(9):1908-21. PubMed ID: 19843481
    [Abstract] [Full Text] [Related]

  • 37. [Seasonal and chronic allergic conjunctivitis in adults with children. Multicenter evaluation of the collyrium N-acetylaspartylglutamic acid (NAAGA) in ophthalmologic and allergy practices].
    Bérard PV, Bérard PV, Mouillac-Gambarelli N, Jourdan-Fonta D.
    Bull Soc Ophtalmol Fr; 1987 Apr 18; 87(4):475-6, 479-83. PubMed ID: 3652358
    [No Abstract] [Full Text] [Related]

  • 38. Clinical efficacy of N-acetyl-aspartyl-glutamic acid nasal spray in children suffering from pollinosis: a double-blind multicentre study.
    Bertrand B, Dab R, Daele J, van Cauwenberge P, van den Broeck R.
    Rhinology; 1995 Sep 18; 33(3):132-4. PubMed ID: 8560162
    [Abstract] [Full Text] [Related]

  • 39. Contrast of the effect of alomide and sodium cromoglycate in the treatment of allergic eye diseases.
    Zhang W, Lin Z.
    Yan Ke Xue Bao; 2000 Sep 18; 16(3):214-6. PubMed ID: 12579651
    [Abstract] [Full Text] [Related]

  • 40. Effect of lodoxamide on in vitro and in vivo conjunctival immediate hypersensitivity responses in rats.
    Yanni JM, Weimer LK, Glaser RL, Lang LS, Robertson SM, Spellman JM.
    Int Arch Allergy Immunol; 1993 Sep 18; 101(1):102-6. PubMed ID: 7684628
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.